Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione

daunorubicin has been researched along with 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kharasch, ED; Novak, RF1

Other Studies

1 other study(ies) available for daunorubicin and 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione

ArticleYear
Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation.
    The Journal of pharmacology and experimental therapeutics, 1983, Volume: 226, Issue:2

    Topics: Animals; Anthraquinones; Antineoplastic Agents; Daunorubicin; Doxorubicin; Lipid Peroxides; Liver; Male; Mitoxantrone; Myocardium; Rabbits; Rats; Rats, Inbred Strains

1983